ω-Conotoxin GVIA Mimetics that Bind and Inhibit Neuronal Cav2.2 Ion Channels
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ω-Conotoxin GVIA Mimetics that Bind and Inhibit Neuronal Cav2.2 Ion Channels
Authors
Keywords
-
Journal
Marine Drugs
Volume 10, Issue 12, Pages 2349-2368
Publisher
MDPI AG
Online
2012-10-22
DOI
10.3390/md10102349
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca2+ channel blockers with analgesic activity
- (2012) Xenia Beebe et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure–activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors
- (2012) Hassan Pajouhesh et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A novel series of pyrazolylpiperidine N-type calcium channel blockers
- (2012) Nalin L. Subasinghe et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of diphenyl lactam derivatives as N-type calcium channel blockers
- (2012) George A. Doherty et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Recent Updates of N-Type Calcium Channel Blockers with Therapeutic Potential for Neuropathic Pain and Stroke
- (2012) Takashi Yamamoto et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- A-1048400 is a novel, orally active, state-dependent neuronal calcium channel blocker that produces dose-dependent antinociception without altering hemodynamic function in rats
- (2011) Victoria E. Scott et al. BIOCHEMICAL PHARMACOLOGY
- Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (CaV2.2) calcium channels
- (2011) David J Adams et al. BRITISH JOURNAL OF PHARMACOLOGY
- Managing the Liabilities Arising from Structural Alerts: A Safe Philosophy for Medicinal Chemists
- (2011) P. J. Edwards et al. CURRENT MEDICINAL CHEMISTRY
- Targeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development
- (2011) Terry Pexton et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Intravenous Injection of Leconotide, an Omega Conotoxin: Synergistic Antihyperalgesic Effects with Morphine in a Rat Model of Bone Cancer Pain
- (2011) Anton Kolosov et al. PAIN MEDICINE
- Structure–activity relationships of diphenylpiperazine N-type calcium channel inhibitors
- (2010) Hassan Pajouhesh et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A potent and selective indole N-type calcium channel (Cav2.2) blocker for the treatment of pain
- (2010) Sriram Tyagarajan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Analgesic Effects of a Substituted N-Triazole Oxindole (TROX-1), a State-Dependent, Voltage-Gated Calcium Channel 2 Blocker
- (2010) C. Abbadie et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- ω-Conotoxin GVIA mimetics based on an anthranilamide core: Effect of variation in ammonium side chain lengths and incorporation of fluorine
- (2009) Asa Andersson et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Low molecular weight non-peptide mimics of ω-conotoxin GVIA
- (2009) Peter J. Duggan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Scaffold-based design and synthesis of potent N-type calcium channel blockers
- (2009) Gerald W. Zamponi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- CNSB004 (Leconotide) Causes Antihyperalgesia Without Side Effects When Given Intravenously: A Comparison with Ziconotide in a Rat Model of Diabetic Neuropathic Pain
- (2009) Anton Kolosov et al. PAIN MEDICINE
- A High-Throughput Assay for Evaluating State Dependence and Subtype Selectivity of Cav2 Calcium Channel Inhibitors
- (2008) Ge Dai et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More